15,829 results match your criteria: "European Respiratory Journal[Journal]"
Tuberculosis in adult migrants in Europe: a TBnet consensus statement.
Eur Respir J
December 2024
Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Introduction: Global migration has increased in recent decades due to war, conflict, persecutions, and natural disasters, but also secondary to increased opportunities related to work or study. Migrants' risk of tuberculosis (TB) differs by reasons for migration, socioeconomic status, mode of travel and TB risk in transit, TB incidence and healthcare provision in country of origin. Despite advances in TB care for migrants and new treatment strategies, decisions for the management of migrants at risk of TB often rely on expert opinions, rather than clinical evidence.
View Article and Find Full Text PDFBacterial misappropriation of host glucose in pneumococcal pneumonia.
Eur Respir J
December 2024
Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK
Genes take the lead: genetic testing becomes the gold standard for diagnosing primary ciliary dyskinesia.
Eur Respir J
December 2024
Departments of Medicine and Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.
Reply to: Is there a kindling effect in COPD exacerbations?
Eur Respir J
December 2024
Observational and Pragmatic Research Institute, Singapore.
https://bit.ly/3O016tT
View Article and Find Full Text PDFThe lung that rules the heart.
Eur Respir J
December 2024
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands
Is there a kindling effect in COPD exacerbations?
Eur Respir J
December 2024
2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.
Extracorporeal Photopheresis for the prevention of rejection after lung transplantation - a prospective randomized controlled trial.
Eur Respir J
December 2024
Department of Thoracic Surgery, Medical University of Vienna, Austria
Rationale: Lung transplant recipients have the worst long-term outcomes of all solid organs due to acute rejection and chronic lung allograft dysfunction (CLAD).
Objective: To investigate the efficacy of ECP as a prophylactic treatment to prevent acute cellular rejection (ACR), CMV infections and reduce the risk of CLAD.
Methods: Single-center prospective randomized controlled trial conducted at Medical University of Vienna between 2018 and 2020.
Sleep disordered breathing (SDB) is considered a risk factor for cardiovascular disease (CVD). Obstructive sleep apnoea (OSA) can be treated with continuous positive airway pressure (CPAP), and central sleep apnoea (CSA), in patients with heart failure with reduced ejection fraction (HFrEF), by peak flow-triggered adaptive servo-ventilation. Presently, there is equipoise as to whether treating SDB prevents cardiovascular events.
View Article and Find Full Text PDFContinuous Positive Airway Pressure and Mandibular Advancement Splints: The CHOICE Multi-center Open-Label Randomized Clinical Trial.
Eur Respir J
December 2024
Department of Oral Health Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
Rationale: Adherence to Continuous Positive Airway Pressure (CPAP) for Obstructive Sleep Apnoea (OSA) continues to be low with high termination rates. Alternative therapies to CPAP are needed.
Objectives: To compare objective adherence to CPAP and Mandibular Advancement Splints (MAS) and to evaluate their effectiveness.
Childhood interstitial lung disease survivors in adulthood: a European collaborative study.
Eur Respir J
December 2024
2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece.
Article Synopsis
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.
Eur Respir J
December 2024
University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter Devon, UK.
Article Synopsis
A breath of the future: a novel human model for COPD and beyond.
Eur Respir J
December 2024
Institute of Lung Health and Immunity, Comprehensive Pneumology Center Munich, Helmholtz Zentrum München, German Center for Lung Research (DZL), Munich, Germany
Identification of an emphysema-specific ATII cell: a step towards understanding impaired lung regeneration in COPD?
Eur Respir J
December 2024
National Heart and Lung Institute, Imperial College London, London, UK
Comment on the European Respiratory Society pulmonary alveolar proteinosis guidelines.
Eur Respir J
December 2024
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Relieving dyspnoea through the brain.
Eur Respir J
December 2024
Research Group Health Psychology, University of Leuven, Leuven, Belgium.
Is asthma remission an important clinical outcome in asthma management?
Eur Respir J
December 2024
Centre for Research on Asthma and Airway Inflammation, Federal University of Santa Catarina, Florianópolis, Brazil
Glycerolipids disrupt regulatory T-cells in asthma.
Eur Respir J
December 2024
Division of Immunology, Boston Children's Hospital, Boston, MA, USA
Uncovering early COPD? The T-slope as a novel CT biomarker for evaluating airway narrowing.
Eur Respir J
December 2024
Robarts Research Institute and Department of Medicine, Division of Respirology, Western University, London, ON, Canada
Are spp. driving COPD exacerbations?
Eur Respir J
November 2024
Manchester Fungal Infection Group, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Manchester, UK
The limits of normal of pulmonary arterial wedge pressure.
Eur Respir J
November 2024
Free University of Brussels, Brussels, Belgium
Reply to: The limits of normal of pulmonary arterial wedge pressure.
Eur Respir J
November 2024
Division of Pulmonology, Dept of Internal Medicine, Medical University of Graz, Graz, Austria
https://bit.ly/4eI3uRy
View Article and Find Full Text PDFDefining adherence phenotype and endotypes to personalise asthma management.
Eur Respir J
November 2024
The Breathing Institute and Pediatric Pulmonary and Sleep Medicine Section, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO, USA.
Outpatient Management of Cancer-Associated Pulmonary Embolism: A Systematic Review and Meta-Analysis.
Eur Respir J
November 2024
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Introduction: Outpatient management of pulmonary embolism (PE) remains controversial in patients with cancer due to their higher risks of mortality, recurrent venous thromboembolism (VTE) and bleeding complications. This systematic review and meta-analysis aimed to evaluate the safety and feasibility of outpatient management of cancer-associated PE.
Methods: We searched MEDLINE, Embase, Cochrane Central, and Scopus databases from inception to May 30, 2024, for studies on outpatient management of cancer-associated PE.